Home Categories API Exemestane
M2229935

Exemestane , 98% , 107868-30-4

Synonym(s):
6-Methyleneandrosta-1,4-diene-3,17-dione;Exemestane

CAS NO.:107868-30-4

Empirical Formula: C20H24O2

Molecular Weight: 296.4

MDL number: MFCD00866994

EINECS: 643-090-2

Pack Size Price Stock Quantity
200mg RMB89.60 In Stock
1g RMB302.40 In Stock
5g RMB1039.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 155.13°C
Boiling point: 453.7±45.0 °C(Predicted)
Density  1.13±0.1 g/cm3(Predicted)
storage temp.  2-8°C
solubility  DMSO: ≥20mg/mL
form  powder
color  white to off-white
optical activity [α]/D +250 to +300°, c = 1 in methanol
InChI InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1
InChIKey BFYIZQONLCFLEV-DAELLWKTSA-N
SMILES C1(=O)C=C2[C@](C)(C=C1)[C@]1([H])[C@]([H])([C@@]3([H])[C@@](CC1)(C)C(=O)CC3)CC2=C
CAS DataBase Reference 107868-30-4(CAS DataBase Reference)

Description and Uses

Exemestane was launched in US and other countries for the treatment of estrogendependent tumors and postmenopausal breast cancer. It is a novel steroidal compound structurally related to the natural substrate for the biosynthesis of estrogen, androstanedione, and can be synthesized by methylidenation of androsta-1, 4-dien- 17beta-ol-3-one in 6 position then oxidation of the alcohol function. Exemestane is an irreversible inactivator of the aromatase enzyme system, so inducing in vivo a dose-related sustained suppression of serum estrogen and minimal endocrine activity. It is the first steroidal representative of the third-generation of orally active aromatase inhibitors with a highly potent and selective mechanism of action, displaying good tolerability and safety profile. In rats with DMBA-induced mammary tumors, 10 to 100 mglkg of exemestan administered po twice-daily for 4 weeks resulted in 76 to 88% regression. In women failing anti-estrogen therapy with tamoxifen, this agent has demonstrated high activity in locally advanced or metastatic disease. In addition, it may also have potential for breast cancer prevention.

antiinfective

Safety

Symbol(GHS) 
GHS08,GHS09
Signal word  Danger
Hazard statements  H360-H411
Precautionary statements  P201-P202-P273-P280-P308+P313-P391
Hazard Codes  T,N
Risk Statements  60-61-51
Safety Statements  53-22-36/37-57
WGK Germany  3
HS Code  29372900
Hazardous Substances Data 107868-30-4(Hazardous Substances Data)

RELATED PRODUCTS